Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Upstream Bio Inc.(UPB) | 0 | 2,036,293 | +2,036,293 | 0 | 33,477 | 21.71% | +33,477 |
| Nuvation Bio(NUVB) | 13,072,340 | 13,072,340 | 0 | 29,936 | 34,772 | 22.55% | +4,837 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 3,891 | 3,689 | 2.39% | -202 |
| enGene Holdings Inc. *W EXP 10/31/202 | 321,502 | 321,502 | 0 | 675 | 271 | 0.18% | -404 |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | 540 | 58 | 0.04% | -482 |
| Immunic Inc(IMUX) | 1,788,160 | 1,788,160 | 0 | 2,950 | 1,788 | 1.16% | -1,162 |
| Alumis Inc | 653,223 | 653,223 | 0 | 6,976 | 5,134 | 3.33% | -1,842 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 3,510 | 1,375 | 0.89% | -2,135 |
| Replimune Group(REPL) | 2,461,319 | 1,975,203 | -486,116 | 26,976 | 23,920 | 15.51% | -3,056 |
| enGene Holdings Inc. COM | 1,076,357 | 526,357 | -550,000 | 7,104 | 3,500 | 2.27% | -3,604 |
| Lexeo Therapeutics(LXEO) | 2,355,904 | 1,184,636 | -1,171,268 | 21,297 | 7,795 | 5.06% | -13,502 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 56,152 | 38,405 | 24.91% | -17,747 |